National Health (Originator Brand) Amendment Determination 2016 (No. 4) (PB 49 of 2016) (Cth)

PB 49 of 2016

National Health (Originator Brand) Amendment Determination 2016 (No. 4)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated         30  May 2016

______________________________________

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

1. Name of Determination

(1)     This Determination is the National Health (Originator Brand) Amendment Determination 2016 (No. 4).

(2)     This Determination may also be cited as PB 49 of 2016.

1. Commencement

This Determination commences on 1 June 2016.

1. Amendments to PB 100 of 2015

Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

Schedule 1     Amendments

(section 3)

[1]   Schedule 1 (table item 1)

Repeal the item, substitute:

1	Acarbose	Glucobay 50 Glucobay 100
1A	Aciclovir	Zovirax Zovirax 200 mg Zovirax 800 mg

[2]   Schedule 1 (after table item 18)

Insert:

18A Azacitidine Vidaza

[3]   Schedule 1 (after table item 74)

Insert:

74A Eplerenone Inspra